Moreover, IL-6 is able to activate the kynurenine pathway leading to an increase of the kynurenic acid production, a compound that has been consistently reported at elevated levels in the CSF or in the post-mortem brain of patients with schizophrenia [38]. Here, IL6 is linked to schizophrenia.